Acquire and retain high-risk patients with CancerIQ Reach
Convert at-risk consumers into motivated patients, even before they set foot in a clinic. Deliver personalized care pathways for the most common cancers and help patients manage their health over time. Grow high-value service lines and generate more revenue. Become the leader in your market for precision cancer care with CancerIQ Reach.
Female: age 46
Grandmother: ovarian cancer
Father: sarcoma (2x)
Meets NCCN testing criteria
Pathogenic mutation: TP53
LATE-STAGE OVARIAN CANCER
Female: age 43
Grandmother: breast cancer
Tyrer-Cuzick Lifetime Risk: 31%
Genetic testing: N/A
Breast MRI: None
LATE-STAGE BREAST CANCER
Male: age 62
Lifestyle: Previous smoker
Smoking history: 25 pack years
Smoking flag in EMR: YES
Low-dose lung CT scan: NO
LATE-STAGE LUNG CANCER
Male: age 58
Family history: Unknown
Colonoscopy recco'd: YES
Colonoscopy adherence: NO
Other CRC Screening: NO
LATE-STAGE COLON CANCER
1. CONNECT
Powerful audience segmentation tools and integrated marketing campaigns make it easy to define and reach target populations.
2. ASSESS
Our comprehensive risk assessment automates Tyrer-Cuzick and NCCN models to capture every patient with elevated cancer risk.
3. EDUCATE
Easy-to-understand results ensure patients understand their cancer risk and how to take action within your health system.
4. PERSONALIZE
Personalized care pathways engage high-risk patients in their health over time and enable providers to track downstream impact.
5. SHARE
Built-in sharing capability empowers patients to easily share results with family members and encourage them to learn their cancer risk.
"CancerIQ provided us with the technology and the expertise to efficiently identify and query patients eligible for a cancer risk assessment, contact patients through targeted outreach, and determine whether patients were eligible for additional services based on their responses. This led to a 6X increase in completed risk assessments, preventive screenings and earlier diagnoses — all without overburdening our IT and marketing teams."
— Rachael Schmidt, Program Director for Cancer Survivorship & Cancer Risk, Nebraska Medicine
“This cutting-edge program we are offering at our new Hennessy Institute helps us fulfill a promise that we have made to transform health care and to be the leader of positive change, by improving the health of all of our communities."
— Robert C. Garrett, FACHE, CEO, Hackensack Meridian Health